IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | +12.5% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $16 | +14.3% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $14 | -70.8% | 400 | -68.7% | 0.00% | -66.7% |
| Q4 2022 | $48 | -99.7% | 1,279 | +219.8% | 0.00% | +200.0% |
| Q3 2022 | $18,000 | +20.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $15,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $15,000 | +25.0% | 400 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -7.7% | 400 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $13,000 | -18.8% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $16,000 | -87.3% | 400 | -85.7% | 0.00% | -83.3% |
| Q1 2021 | $126,000 | -50.2% | 2,800 | -37.4% | 0.01% | -57.1% |
| Q4 2020 | $253,000 | +19.3% | 4,471 | -0.3% | 0.01% | 0.0% |
| Q3 2020 | $212,000 | -47.1% | 4,483 | -34.2% | 0.01% | -51.7% |
| Q2 2020 | $401,000 | +95.6% | 6,809 | +56.5% | 0.03% | +70.6% |
| Q1 2020 | $205,000 | -22.9% | 4,350 | -1.3% | 0.02% | -5.6% |
| Q4 2019 | $266,000 | – | 4,409 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |